Stocktoria
Cigna Group CI
NYSE · XNYS · stock · Hospital & Medical Service Plans · website · IPO 1982-04-01
Chart by TradingView
7/9
Piotroski F — financial health
1.4
Altman Z″ — distress risk · grey
27.0%
Dividend payout · safe
Valuation · market cap as of 2026-06-29
Market cap$74.8B
P / E12.6×
P / S0.3×
P / B1.8×
Dividend yield2.15%
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B |
| Operating income | $9.2B | $9.4B | $8.5B | $8.4B | $7.9B |
| Net income | $6.0B | $3.4B | $5.2B | — | — |
| Operating cash flow | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B |
| Total assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B |
| Total liabilities | $116.0B | $114.6B | $106.4B | $99.1B | $107.7B |
| Shareholders' equity | $41.9B | $41.2B | $46.2B | $44.7B | $47.0B |
| Ratios | |||||
| Operating margin | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% |
| Net margin | 2.2% | 1.4% | 2.6% | — | — |
| Return on assets | 3.8% | 2.2% | 3.4% | — | — |
| Return on equity | 14.2% | 8.3% | 11.2% | — | — |
| Current ratio | 0.85 | 0.84 | 0.77 | 0.73 | 0.83 |
| Revenue growth | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Bridgewater Associates, LP | 228,493 | $61.0M |
| RENAISSANCE TECHNOLOGIES LLC | 218,939 | $58.4M |
| Point72 Asset Management, L.P. | 36,803 | $9.8M |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.4 (grey)
- Working capital / assets -0.054
- Retained earnings / assets 0.303
- EBIT / assets 0.058
- Equity / liabilities 0.361
Sector peers
IX · MUFG · MFG · NMR · UNH · BRK-A · all Finance, Insurance & Real Estate →
Source: SEC EDGAR filings · CIK 0001739940 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.